Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Loxo Oncology CS (LOXO)

Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Loxo Oncology CS 281 TRESSER BOULEVARD 9TH FLOOR STAMFORD CT 06901 USA

www.loxooncology.com P: 203-653-3880

Description:

Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.

Key Statistics

Overview:

Market Capitalization, $K 7,182,943
Shares Outstanding, K 30,615
Annual Sales, $ 21,300 K
Annual Net Income, $ -148,880 K
Last Quarter Sales, $ 42,470 K
Last Quarter Net Income, $ -27,060 K
60-Month Beta 2.51
% of Insider Shareholders 17.10%
% of Institutional Shareholders 96.42%

Growth:

1-Year Return 123.68%
3-Year Return 1,124.74%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.89 on 11/08/18
Latest Earnings Date 03/07/19
Earnings Per Share ttm -2.09
EPS Growth vs. Prev Qtr -128.21%
EPS Growth vs. Prev Year 20.54%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LOXO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.42%
Return-on-Assets % -8.66%
Profit Margin % -698.97%
Debt/Equity N/A
Price/Sales 49.61
Price/Cash Flow N/A
Price/Book 18.85
Book Value/Share 12.45
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar